Boothbay Fund Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Boothbay Fund Management's DXCM Position: Q2 2026 in Review
Boothbay Fund Management increased its DexCom (DXCM) stake by 98% in Q2 2026, buying an estimated $293K and bringing the position to 8,883 shares worth $598K. The position accounts for 0.01% of the portfolio, ranked #1384.
Boothbay Fund Management first reported a position in DXCM in Q4 2016 and has held it in 14 quarters since. The position peaked at $5.94M in Q3 2023. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Boothbay Fund Management held 8,883 shares of DexCom worth $598K as of Q2 2026.
- Boothbay Fund Management bought 4,397 DexCom shares in Q2 2026, an estimated $293K.
- DexCom made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1384 holding.
- Boothbay Fund Management first reported a position in DexCom in Q4 2016 and has held it in 14 quarters since.
- Boothbay Fund Management's DexCom position peaked at $5.94M in Q3 2023.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.